Fintel reports that on March 12, 2026, Bernstein upgraded their outlook for CVS Health (NYSE:CVS) from Market Perform to Outperform.
Analyst Price Forecast Suggests 26.44% Upside
As of February 25, 2026, the average one-year price target for CVS Health is $95.74/share. The forecasts range from a low of $79.79 to a high of $110.25. The average price target represents an increase of 26.44% from its latest reported closing price of $75.72 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for CVS Health is 365,688MM, a decrease of 8.54%. The projected annual non-GAAP EPS is 10.72.
What is the Fund Sentiment?
There are 2,257 funds or institutions reporting positions in CVS Health. This is an decrease of 763 owner(s) or 25.26% in the last quarter. Average portfolio weight of all funds dedicated to CVS is 0.28%, an increase of 26.74%. Total shares owned by institutions decreased in the last three months by 11.78% to 1,219,685K shares. 
The put/call ratio of CVS is 0.77, indicating a bullish outlook.
What are Other Shareholders Doing?
Capital World Investors holds 67,663K shares representing 5.32% ownership of the company. In its prior filing, the firm reported owning 68,382K shares , representing a decrease of 1.06%. The firm increased its portfolio allocation in CVS by 3.70% over the last quarter.
Dodge & Cox holds 62,510K shares representing 4.91% ownership of the company. In its prior filing, the firm reported owning 73,177K shares , representing a decrease of 17.06%. The firm decreased its portfolio allocation in CVS by 10.04% over the last quarter.
Jpmorgan Chase holds 31,203K shares representing 2.45% ownership of the company. In its prior filing, the firm reported owning 35,275K shares , representing a decrease of 13.05%. The firm decreased its portfolio allocation in CVS by 2.43% over the last quarter.
AWSHX - WASHINGTON MUTUAL INVESTORS FUND holds 30,670K shares representing 2.41% ownership of the company. No change in the last quarter.
Geode Capital Management holds 29,040K shares representing 2.28% ownership of the company. In its prior filing, the firm reported owning 28,988K shares , representing an increase of 0.18%. The firm increased its portfolio allocation in CVS by 2.04% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
